(Q38161822)

30 August 2017

title

Metabolomics insights into pathophysiological mechanisms of nephrology (English)

1 reference

30 August 2017

1 reference

1 reference

Aihua Zhang

1

1 reference

30 August 2017

Hui Sun

series ordinal

2

1 reference

30 August 2017

Shi Qiu

series ordinal

3

1 reference

30 August 2017

Xijun Wang

series ordinal

4

1 reference

30 August 2017

publication date

12 November 2013

1 reference

International Urology and Nephrology

30 August 2017

published in

1 reference

30 August 2017

volume

46

1 reference

30 August 2017

issue

5

1 reference

30 August 2017

page(s)

1025-1030

1 reference

Metabolomics in the study of kidney diseases

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

1H NMR spectroscopy analysis of metabolites in the kidneys provides new insight into pathophysiological mechanisms: applications for treatment with Cordyceps sinensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Urine metabolomics analysis for kidney cancer detection and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC-MS system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Urinary metabolomics in monitoring acute tubular injury of renal allografts: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Biological markers of acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

New insights into uremia-induced alterations in metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Urine metabolomics for kidney cancer detection and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Future perspectives of Chinese medical formulae: chinmedomics as an effector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Marking renal injury: can we move beyond serum creatinine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Serum metabolomic profiles from patients with acute kidney injury: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Serum metabolite concentrations and decreased GFR in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

A pilot metabolic profiling study in serum of patients with chronic kidney disease based on (1) H-NMR-spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Application of ex vivo (1)H NMR metabonomics to the characterization and possible detection of renal cell carcinoma metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

LC-MS based serum metabonomic analysis for renal cell carcinoma diagnosis, staging, and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

(1)H NMR metabonomic analysis in renal cell carcinoma: a possible diagnostic tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Metabolic profiling reveals key metabolic features of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Urinary metabolic phenotyping the slc26a6 (chloride-oxalate exchanger) null mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

A proton nuclear magnetic resonance-based metabonomics study of metabolic profiling in immunoglobulin a nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Urine metabolomics analysis for biomarker discovery and detection of jaundice syndrome in patients with liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Recent advances in metabolomics in neurological disease, and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-013-0600-2

Metabolomic changes and protective effect of (L)-carnitine in rat kidney ischemia/reperfusion injury

21 January 2018

1 reference

12 December 2020

Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy

1 reference

12 December 2020

Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease

1 reference

12 December 2020

1H NMR-based metabonomics study on serum of renal interstitial fibrosis rats induced by unilateral ureteral obstruction

1 reference

12 December 2020

Evaluation of the proximal tubular function in individuals with primary renal hypouricemia: an NMR-based metabonomic study

1 reference

12 December 2020

Urinary biomarkers for the detection of renal injury

1 reference

12 December 2020

Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity.

1 reference

12 December 2020

Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model

1 reference

12 December 2020

10.1007/S11255-013-0600-2

Identifiers

DOI

1 reference

30 August 2017

1 reference